BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 33577977)

  • 1. Long non-coding RNAs in colorectal cancer: Novel oncogenic mechanisms and promising clinical applications.
    Yang Y; Yan X; Li X; Ma Y; Goel A
    Cancer Lett; 2021 Apr; 504():67-80. PubMed ID: 33577977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNAs in colorectal cancer: Biomarkers to therapeutic targets.
    Chen LJ; Chen X; Niu XH; Peng XF
    Clin Chim Acta; 2023 Mar; 543():117305. PubMed ID: 36966964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentials of long non-coding RNAs as biomarkers of colorectal cancer.
    Lv Y; Wang Y; Zhang Z; Bao J; Su H
    Clin Transl Oncol; 2022 Sep; 24(9):1715-1731. PubMed ID: 35581419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA signature in colorectal cancer.
    Ghafouri-Fard S; Hussen BM; Gharebaghi A; Eghtedarian R; Taheri M
    Pathol Res Pract; 2021 Jun; 222():153432. PubMed ID: 33857856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNAs in colorectal cancer.
    Xie X; Tang B; Xiao YF; Xie R; Li BS; Dong H; Zhou JY; Yang SM
    Oncotarget; 2016 Feb; 7(5):5226-39. PubMed ID: 26637808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulated long noncoding RNAs LINC02163 and FEZF1-AS1 exert oncogenic roles in colorectal cancer.
    Tian Y; Zhou J; Zou Y; Luo B; Liu Q; Cao X
    Anticancer Drugs; 2021 Jan; 32(1):66-73. PubMed ID: 32932277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Exosomal Long Non-Coding RNAs Serve as Biomarkers for Early Detection of Colorectal Cancer.
    Hu D; Zhan Y; Zhu K; Bai M; Han J; Si Y; Zhang H; Kong D
    Cell Physiol Biochem; 2018; 51(6):2704-2715. PubMed ID: 30562751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-coding RNAs as emerging regulators and biomarkers in colorectal cancer.
    Kishore C; Karunagaran D
    Mol Cell Biochem; 2022 Jun; 477(6):1817-1828. PubMed ID: 35332394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-coding RNAs as Biomarkers for Survival in Colorectal Cancer Patients.
    Andrabi MQ; Kesavan Y; Ramalingam S
    Curr Aging Sci; 2024; 17(1):5-15. PubMed ID: 36733201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
    Fan Q; Liu B
    J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of non-coding RNAs as novel biomarkers for detection of colorectal cancer progression through interaction with the cell signaling pathways.
    Esmaeili M; Keshani M; Vakilian M; Esmaeili M; Peymani M; Seyed Forootan F; Chau TL; Göktuna SI; Zaker SR; Nasr Esfahani MH; Ghaedi K
    Gene; 2020 Aug; 753():144796. PubMed ID: 32450203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNAs: Potential Novel Prognostic and Diagnostic Biomarkers in Colorectal Cancer.
    Dastmalchi N; Safaralizadeh R; Nargesi MM
    Curr Med Chem; 2020; 27(30):5067-5077. PubMed ID: 30827228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linc00659, a long noncoding RNA, acts as novel oncogene in regulating cancer cell growth in colorectal cancer.
    Tsai KW; Lo YH; Liu H; Yeh CY; Chen YZ; Hsu CW; Chen WS; Wang JH
    Mol Cancer; 2018 Mar; 17(1):72. PubMed ID: 29523145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation Mechanism of Long Noncoding RNAs in Colon Cancer Development and Progression.
    Tang X; Qiao X; Chen C; Liu Y; Zhu J; Liu J
    Yonsei Med J; 2019 Apr; 60(4):319-325. PubMed ID: 30900417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decoding the regulatory landscape of lncRNAs as potential diagnostic and prognostic biomarkers for gastric and colorectal cancers.
    Zabeti Touchaei A; Vahidi S; Samadani AA
    Clin Exp Med; 2024 Jan; 24(1):29. PubMed ID: 38294554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.
    Perakis SO; Thomas JE; Pichler M
    Adv Exp Med Biol; 2016; 937():183-204. PubMed ID: 27573901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNAs AC156455.1 and AC104532.2 as Biomarkers for Diagnosis and Prognosis in Colorectal Cancer.
    Kuang F; Luo D; Zhou M; Du J; Yang J
    Dis Markers; 2022; 2022():4872001. PubMed ID: 36277972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of noncoding RNAs in colorectal cancer chemoresistance.
    Wei L; Wang X; Lv L; Zheng Y; Zhang N; Yang M
    Cell Oncol (Dordr); 2019 Dec; 42(6):757-768. PubMed ID: 31359293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA FOXP4-AS1 is an unfavourable prognostic factor and regulates proliferation and apoptosis in colorectal cancer.
    Li J; Lian Y; Yan C; Cai Z; Ding J; Ma Z; Peng P; Wang K
    Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27790757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.